Newmed Energ Pu (NWMD) AI Stock Analysis

• Market Cap: 17.27B
• Dividend Yield: 4.99%
• Average Volume (3M): 922.22K
• Price to Earnings (P/E): 9.0
• Beta (1Y): 1.20
• Revenue Growth: 6.84%
• EPS Growth: 18.87%
• Country: IL
• Employees: 23
• Sector: Energy
• Sector Strength: 46
• Industry: Oil & Gas Exploration & Production
• EPS (TTM): 35.80
• Shares Outstanding: 1,173,814,700
• 10 Day Avg. Volume: 884,630
• 30 Day Avg. Volume: 922,221
• PEG Ratio: N/A
• Price to Book (P/B): 2.62
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 9.67
• Enterprise Value/Market Cap: 0.37
• Enterprise Value/Revenue: 1.44
• Enterprise Value/Gross Profit: 8.33
• Enterprise Value/Ebitda: 1.87
• 1Y Price Target: 1,333.89
• Price Target Upside: -9.63% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 73 Outperform
• Price Target: 1,630.00 ▲(10.43%Upside)

Newmed Energ Pu has a robust financial performance with strong profitability and cash flow metrics, though revenue growth needs attention. The technical analysis indicates upward momentum but warns of overbought conditions. Valuation metrics suggest the stock is undervalued with a high dividend yield, adding to its attractiveness. These factors contribute to a positive overall stock score, with room for improvement in revenue growth.

Newmed Energ Pu Business Overview & Revenue Model

Company Description

Newmed Energy Pu (NWMD) is a company engaged in the energy sector, focusing on the exploration, development, and production of natural gas and oil resources. The company operates within the energy and utilities industry, delivering essential energy products and services to a diverse range of markets and customers.

How the Company Makes Money

Newmed Energy Pu generates revenue primarily through the extraction and sale of natural gas and oil. The company explores and develops energy resources, which are then produced and distributed to various markets, including industrial, commercial, and residential sectors. Key revenue streams include the sale of extracted natural gas and oil, as well as potential partnerships with other energy companies for joint exploration and development initiatives. Additionally, Newmed Energy may engage in long-term supply contracts with domestic and international buyers, providing a stable and predictable revenue flow.

Newmed Energ Pu Financial Statement Overview

Summary

Newmed Energ Pu demonstrates solid financial health with strong profitability and cash flow metrics, although revenue growth has slightly declined. The balance sheet reflects a balanced leverage position with good return on equity, suggesting stability and efficient use of resources. Overall, the financial outlook is positive with potential for growth if revenue trends are addressed.

Income Statement

The company exhibits strong profitability with a high gross profit margin of 67.75% and a solid EBIT margin of 64.63% in TTM (Trailing-Twelve-Months). However, the revenue growth rate shows a slight decline of 1.60% from the previous year. Despite this, the net profit margin remains robust at 46.50%, indicating efficient cost management.

Balance Sheet

Newmed Energ Pu has a moderate debt-to-equity ratio of 0.86, which suggests a balanced leverage position. The equity ratio is at 45.39%, indicating a reasonable level of equity funding. Return on Equity (ROE) is strong at 28.20%, demonstrating effective use of shareholders' funds to generate profits.

Cash Flow

The company's free cash flow to net income ratio is favorable at 0.96, showing efficient conversion of profits into cash. Operating cash flow to net income ratio is also strong at 1.18, reflecting good cash generation relative to net profits. Free cash flow growth is positive at 7.76%, indicating healthy cash flow expansion.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
1.12B	1.14B	934.60M	1.14B	882.54M	919.12M
	Gross Profit
757.60M	718.10M	780.70M	701.70M	518.11M	535.48M
	EBIT
722.60M	704.10M	679.40M	678.80M	496.43M	513.15M
	EBITDA
875.00M	874.80M	782.70M	819.50M	633.90M	454.00M
	Net Income Common Stockholders
519.90M	524.60M	433.60M	469.70M	404.90M	365.30M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
234.50M	384.50M	186.70M	418.30M	340.85M	239.35M
	Total Assets
4.50B	3.99B	3.85B	3.94B	3.85B	4.58B
	Total Debt
3.28B	1.63B	1.82B	2.16B	2.22B	3.25B
	Net Debt
3.11B	1.58B	1.79B	2.13B	2.00B	3.18B
	Total Liabilities
3.69B	2.21B	2.33B	2.65B	2.91B	3.59B
	Stockholders Equity
813.51M	1.79B	1.51B	1.29B	938.54M	997.70M
Cash Flow		Free Cash Flow
499.20M	463.30M	423.10M	405.80M	423.25M	163.59M
	Operating Cash Flow
613.40M	577.50M	559.50M	504.70M	453.64M	328.68M
	Investing Cash Flow
-212.70M	-114.20M	36.10M	-273.50M	982.04M	-241.82M
	Financing Cash Flow
-453.30M	-441.20M	-588.90M	-429.10M	-1.29B	-187.92M

Newmed Energ Pu Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1476.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1476 is above the 20-day moving average (MA) of 1424.81, above the 50-day MA of 1333.30, and above the 200-day MA of 1159.83, indicating a bullish trend. The MACD of 38.90 indicates Negative momentum. The RSI at 65.79 is Neutral, neither overbought nor oversold. The STOCH value of 81.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ENOG	82 Outperform	£1.70B	11.52	17.50%	10.05%	-9.80%	-1.98%
NWMD	73 Outperform	17.27B	9.00	30.42%	4.99%	6.84%	18.87%
Sector *	57 Neutral	$7.22B	3.11	-4.49%	5.63%	0.82%	-49.15%

Newmed Energ Pu Corporate Events

Newmed Energ Pu Withdraws Class Action in Settlement with Chevron

Newmed Energ Pu announced the withdrawal of a class action lawsuit against Chevron Mediterranean Limited, as part of a broader settlement negotiation. The agreement, reached with mutual consent, was filed with authorities and includes scheduled hearings to ensure compliance and implementation of the terms. The companies will continue collaborative efforts to resolve outstanding issues and maintain shareholder updates following key hearings.